Gates Foundation Strategic Investment Fund Logo
Share this page:

Xconomy: Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis

By David Holley

Arsanis, a Waltham, MA-based biotech co-founded by scientist and entrepreneur Tillman Gerngross to develop treatments for bacterial and viral infections, has raised a $45.5 million investment led by the Bill & Melinda Gates Foundation to finance a mid-stage clinical trial for its lead drug program.

Read the full article here.